A detailed history of Select Asset Management & Trust transactions in Pfizer Inc stock. As of the latest transaction made, Select Asset Management & Trust holds 32,934 shares of PFE stock, worth $904,367. This represents 0.37% of its overall portfolio holdings.

Number of Shares
32,934
Previous 38,409 14.25%
Holding current value
$904,367
Previous $1.07 Million 13.6%
% of portfolio
0.37%
Previous 0.44%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$25.26 - $29.6 $138,298 - $162,060
-5,475 Reduced 14.25%
32,934 $921,000
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $4,142 - $4,756
160 Added 0.42%
38,409 $1.07 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $2,795 - $3,631
-107 Reduced 0.28%
38,249 $1.1 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $9,851 - $11,515
307 Added 0.81%
38,356 $1.27 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $166,079 - $192,150
-4,598 Reduced 10.78%
38,049 $1.4 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $193,916 - $252,451
4,923 Added 13.05%
42,647 $1.74 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $586,371 - $695,252
-12,602 Reduced 25.04%
37,724 $1.98 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $3.65 Million - $4.53 Million
-79,886 Reduced 61.35%
50,326 $2.61 Million
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $479,312 - $710,500
11,600 Added 9.78%
130,212 $7.69 Million
Q3 2021

Nov 09, 2021

SELL
$39.25 - $50.42 $883,125 - $1.13 Million
-22,500 Reduced 15.94%
118,612 $5.1 Million
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $944,468 - $1.07 Million
26,301 Added 22.91%
141,112 $5.53 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $3.85 Million - $4.34 Million
114,811 New
114,811 $4.16 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Select Asset Management & Trust Portfolio

Follow Select Asset Management & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Select Asset Management & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Select Asset Management & Trust with notifications on news.